Global Cold Plasma Market Projected to Reach $3.03 Billion by 2031
News fromCourierPR · 3 min read
DELRAY BEACH, Fla., Sept. 7, 2026 /CourierPR/ -- According to a new report by MarketsandMarkets™, the global cold plasma market is projected to reach $3.03 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.1% from $2.15 billion in 2026. The research highlights the expanding applications of cold plasma across various industries, including healthcare, electronics and semiconductor, food, textile, packaging, automotive, and industrial manufacturing.
In 2025, the European cold plasma market accounted for 33.9% of the total market share. By 2031, the medical industry segment is expected to register the highest CAGR of 8.5%. The surface treatment and activation segment is predicted to dominate the market with a 24.7% share in 2025. Atmospheric cold plasma, which made up 63.2% of the market in 2025, is expected to continue its dominance due to its suitability for various applications.
The growth of the cold plasma market is supported by the increasing adoption of this technology across various industries. Cold plasma enables low-temperature surface treatment, cleaning, activation, coating, sterilization, and decontamination, making it suitable for heat-sensitive materials and complex components. Advancements in atmospheric-pressure and low-pressure plasma systems, portable devices, automated plasma treatment, plasma-enabled coatings, and application-specific systems are expanding the technology's commercial use.
The polymer and plastics industry segment is expected to register the highest share of the global cold plasma market in 2025. The rising demand for surface activation, improved adhesion, wettability, printability, and bonding of plastic components and packaging materials is driving this growth. The adoption of cold plasma technology is increasing across sectors such as automotive, electronics, packaging, and industrial manufacturing due to its ability to precisely modify surfaces without altering the material's bulk properties.
In the wound healing segment, cold plasma is anticipated to register the highest CAGR in the market. Several factors, including the increasing prevalence of chronic and difficult-to-heal wounds, the demand for non-invasive wound care solutions, and the growing application of cold plasma in infection control, tissue regeneration, and wound healing, are driving this growth. Cold plasma's non-thermal nature enables treatment without causing significant damage to surrounding healthy tissue, and its antimicrobial properties help reduce pathogens associated with wounds.
The atmospheric cold plasma segment is projected to expand rapidly in the cold plasma market in 2025. This growth is driven by its increasing use in surface treatments, activation, cleaning, coating, sterilization, and wound healing. The ability to operate at atmospheric pressure without vacuum chambers allows for continuous, scalable, and cost-effective processing. This makes atmospheric cold plasma suitable for various applications across industries such as polymers and plastics, textiles, medicine, food and agriculture, automotive, and electronics.
The Asia Pacific market is expected to register the highest growth rate in the forecast period. The increasing adoption of cold plasma technologies across sectors such as healthcare, electronics, textiles, and the polymer and plastics industries is driving this growth. Additionally, expanding manufacturing activities, improving healthcare infrastructure, and supportive government initiatives are expected to further enhance the region's growth rate in the cold plasma market.
Key players in the cold plasma market include Nordson Corporation, ADTEC Plasma Technology, Bodycote, PVA TePLa AG, and others. These companies are focusing on expanding their capabilities in medical plasma, atmospheric plasma, surface treatment, and advanced manufacturing. Investment funding has been increasing, with activity accelerating after 2024 as companies focused on expanding their capabilities in medical plasma, atmospheric plasma, surface treatment, and advanced manufacturing.
The market is moderately consolidated, with the top five players, Nordson Corporation, Bodycote, Mycronic, Judges Scientific plc, and PVA TePla AG, accounting for approximately 83.0-86.0% of the market in 2025. The remaining market is held by Plasmatreat GmbH, ADTEC Plasma Technology, Apyx Medical Corporation, Tantec, Enercon Industries, AcXys Technologies, and other regional players, which primarily compete in specific applications such as surface activation, precision cleaning, etching, wound care, sterilization, and plasma treatment of polymers and textiles.
Mergers and acquisitions in the cold plasma market increased in 2025 compared with 2024, driven by growing demand for advanced plasma technologies in semiconductor and electronics manufacturing. Mycronic's acquisition of Surfx Technologies for approximately $87.5 million in 2025, strengthening Mycronic's atmospheric plasma capabilities for surface cleaning and treatment applications, was a notable deal.